Jamjoom Pharma’s Financial Results in Q1/2026
Jamjoom Pharma’s Financial Results in Q1/2026 1Q 2026 Financial Summary SAR (mn) 1Q 2026 1Q 2025 YOY Δ% Revenue 481.4 457.5 +5% Gross profit 310.4 292.8 +6% Operating profit 172.4 158.2 +9% Net profit 168.2 157.0 +7% EBITDA 186.7 172.4 +8% FCF 180.5 156.6 +15% EPS 2.4 2.2 +7% JEDDAH, 23rd April 2026 –…